Gerhard Hildebrandt View Appointment Options Gerhard Hildebrandt Appointment Options Research & Selected Publications Share Copy Link Email Link Print Page Facebook X Instagram LinkedIn Back Gmail Outlook Apple Mail Yahoo! Mail Appointment Options Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you. Request an Appointment Call Us Refer a Patient Research & Selected Publications Chemotherapy-induced acceleration of DNA methylation-based biological age in breast cancer Chemotherapy-induced acceleration of DNA methylation-based biological age in breast cancer Authors: Nannini DR, Cortese R, VonTungeln C, Hildebrandt GC Journal & Year: Epigenetics | 2024 Inhibiting AGTR1 reduces AML burden and protects the heart from cardiotoxicity in mouse models Inhibiting AGTR1 reduces AML burden and protects the heart from cardiotoxicity in mouse models Authors: Pan Y, Wang C, Zhou W, [...]one or more additional authors omitted Hildebrandt G, Kang X Journal & Year: Sci Transl Med | 2024 A dyadic analysis of financial toxicity and health-related quality of life among bone marrow transplant patients and their caregivers A dyadic analysis of financial toxicity and health-related quality of life among bone marrow transplant patients and their caregivers Authors: Edward JS, Rayens MK, McLouth LE, [...]one or more additional authors omitted Hildebrandt G Journal & Year: Psychooncology | 2024 Role of Defibrotide in the Prevention of Murine Model Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation Role of Defibrotide in the Prevention of Murine Model Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation Authors: Palaniyandi S, Kumari R, Strattan E, [...]one or more additional authors omitted Hildebrandt GC Journal & Year: Transplant Cell Ther | 2023 Combinatorial inhibition of Tec kinases BTK and ITK is beneficial in ameliorating murine sclerodermatous chronic graft versus host disease Combinatorial inhibition of Tec kinases BTK and ITK is beneficial in ameliorating murine sclerodermatous chronic graft versus host disease Authors: Palaniyandi S, Strattan E, Kumari R, [...]one or more additional authors omitted Hildebrandt GC Journal & Year: Bone Marrow Transplant | 2023
